Anebulo Pharmaceuticals, Inc. (ANEB) Financials
ANEB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 9.4 million | 1.5 million |
| Sept. 30, 2025 | 10.7 million | 963821 |
| June 30, 2025 | 12.1 million | 487688 |
| March 31, 2025 | 14.0 million | 546032 |
ANEB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -1.3 million | 198530 |
| Sept. 30, 2025 | -1.3 million | 237644 |
| June 30, 2025 | -1.7 million | 340304 |
| March 31, 2025 | -1.6 million | 255267 |
ANEB Net Income
No data available :(
ANEB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 9.0 million | - | - |
| Sept. 30, 2025 | 10.4 million | - | - |
| June 30, 2025 | 11.6 million | - | - |
| March 31, 2025 | 13.3 million | - | - |
ANEB Shares Outstanding
ANEB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | - | 1.2 million | 1.5 million | - |
| Sept. 30, 2025 | - | 809991 | 1.5 million | - |
| June 30, 2025 | - | 1.1 million | 1.2 million | - |
| March 31, 2025 | - | 638324 | 1.3 million | - |
ANEB Cost of Revenue
No data available :(
ANEB
Price: $0.48
52 week price:
Earnings Per Share: -0.18 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1471
Market Capitalization: 15.3 million